[Systemic availability of prednisolone following oral administration of prednisone]. 1984

B M Frey, and A W Brandenberger, and F J Frey, and H R Widmer

UI MeSH Term Description Entries
D008297 Male Males
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

B M Frey, and A W Brandenberger, and F J Frey, and H R Widmer
July 1976, Journal of pharmaceutical sciences,
B M Frey, and A W Brandenberger, and F J Frey, and H R Widmer
January 1999, Drug metabolism and disposition: the biological fate of chemicals,
B M Frey, and A W Brandenberger, and F J Frey, and H R Widmer
April 1988, Presse medicale (Paris, France : 1983),
B M Frey, and A W Brandenberger, and F J Frey, and H R Widmer
January 1998, Eye (London, England),
B M Frey, and A W Brandenberger, and F J Frey, and H R Widmer
May 2023, British journal of clinical pharmacology,
B M Frey, and A W Brandenberger, and F J Frey, and H R Widmer
January 1993, European journal of clinical pharmacology,
B M Frey, and A W Brandenberger, and F J Frey, and H R Widmer
August 1958, Dermatologische Wochenschrift,
B M Frey, and A W Brandenberger, and F J Frey, and H R Widmer
January 1981, Digestion,
B M Frey, and A W Brandenberger, and F J Frey, and H R Widmer
December 1955, Journal of the American Medical Association,
B M Frey, and A W Brandenberger, and F J Frey, and H R Widmer
February 1981, European journal of clinical pharmacology,
Copied contents to your clipboard!